Dataset Information
The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis.
Ontology highlight
ABSTRACT: Objectives
Severe malaria remains a deadly disease for many young children in low- and middle-income countries. Levels of interleukin (IL)-6 have been shown to identify cases of severe malaria and associate with severity, but it is unknown if this association is causal.Methods
A single nucleotide polymorphism (SNP; rs2228145) in the IL-6 receptor was chosen as a genetic variant that is known to alter IL-6 signaling. We tested this, then took this forward as an instrument to perform Mendelian randomization (MR) in MalariaGEN, a large cohort study of patients with severe malaria at 11 worldwide sites.Results
In MR analyses using rs2228145, we did not identify an effect of decreased IL-6 signaling on severe malaria (odds ratio 1.14, 95% confidence interval 0.56-2.34, P = 0.713). The estimates of the association with any severe malaria subphenotype were similarly null, although with some imprecision. Further analyses using other MR approaches had similar results.Conclusion
These analyses do not support a causal role for IL-6 signaling in the development of severe malaria. This result suggests IL-6 may not be causal for severe outcomes in malaria, and that therapeutic manipulation of IL-6 is unlikely to be a suitable treatment for severe malaria.
SUBMITTER: Hamilton F
PROVIDER: S-EPMC10728776 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Publications
The effect of interleukin-6 signaling on severe malaria: A Mendelian randomization analysis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20230216
<h4>Objectives</h4>Severe malaria remains a deadly disease for many young children in low- and middle-income countries. Levels of interleukin (IL)-6 have been shown to identify cases of severe malaria and associate with severity, but it is unknown if this association is causal.<h4>Methods</h4>A single nucleotide polymorphism (SNP; rs2228145) in the IL-6 receptor was chosen as a genetic variant that is known to alter IL-6 signaling. We tested this, then took this forward as an instrument to perfo ...[more]
